LivaNova (LIVN) Deferred Taxes (2015 - 2026)
LivaNova (LIVN) reported Deferred Taxes of $1.8 million for Q1 2026, down 18.72% on a YoY basis from $2.2 million in Q1 2025, and up 150.51% sequentially from -$3.6 million in Q4 2025.
LivaNova (LIVN) Deferred Taxes (2015 - 2026) Analysis & Trends
LivaNova (LIVN) has 12 years of Deferred Taxes data on file, last reported at $1.8 million in Q1 2026.
- For the quarter ending Q1 2026, Deferred Taxes fell 18.72% year-over-year to $1.8 million; the trailing twelve-month figure through Mar 2026 stood at $35000.0 (down 99.17% YoY), and the FY2025 full-year result was $455000.0, down 93.3% from the prior year.
- Deferred Taxes rose to $1.8 million in Q1 2026, from -$3.6 million in the prior quarter.
- In the past five years, Deferred Taxes ranged from a high of $4.8 million in Q1 2024 to a low of -$116.3 million in Q4 2023.
- A 5-year average of -$7.0 million and a median of $519000.0 in 2025 frame the typical range for Deferred Taxes.
- Across the five-year window, Deferred Taxes plunged 27029.63% in 2023 and surged 6415.79% in 2024, its largest moves.
- Tracing LIVN's Deferred Taxes over 5 years: stood at $432000.0 in 2022, then sank by 27029.63% to -$116.3 million in 2023, then soared by 98.02% to -$2.3 million in 2024, then plunged by 57.14% to -$3.6 million in 2025, then jumped by 150.51% to $1.8 million in 2026.
- Business Quant data shows LIVN's Deferred Taxes at $1.8 million in Q1 2026, -$3.6 million in Q4 2025, and $1.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -33.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -8.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -351.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -9.40 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 7.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 51.51 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | LivaNova | 4.30 Bn | 3.76 Bn | 243.75 Mn | 1.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.82 Mn |
| Dec 31, 2025 | -3.61 Mn |
| Sep 30, 2025 | 1.30 Mn |
| Jun 30, 2025 | 519,000.00 |
| Mar 31, 2025 | 2.24 Mn |
| Dec 31, 2024 | -2.30 Mn |
| Sep 30, 2024 | 3.54 Mn |
| Jun 30, 2024 | 756,000.00 |
| Mar 31, 2024 | 4.80 Mn |
| Dec 31, 2023 | -116.34 Mn |
| Sep 30, 2023 | 1.82 Mn |
| Jun 30, 2023 | 161,000.00 |
| Mar 31, 2023 | -76,000.00 |
| Dec 31, 2022 | 432,000.00 |
| Sep 30, 2022 | 332,000.00 |
| Dec 31, 2021 | 3.88 Mn |
| Sep 30, 2021 | -1.94 Mn |
| Jun 30, 2021 | 876,000.00 |
| Mar 31, 2021 | 37,000.00 |
| Dec 31, 2020 | -4.07 Mn |